All News #Library
Others
Cardiol Therapeutics Expands U.S. MAVERIC Phase 3 Trial Network
28 Apr 2026 //
PR NEWSWIRE
Cardiol`s CRD-38 May Stand Out In Heart Failure Space: GlobalData
02 Mar 2025 //
EXPRESSPHARMA
Hope On The Horizon: MAvERIC-Pilot Shows Heartfelt Progress For Patients
17 Jun 2024 //
ACCESSWIRE
Cardiol begins subject enrolment in recurrent pericarditis trial
18 Jan 2023 //
CLINICAL TRIALS ARENA
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed PO
02 Nov 2021 //
NEWSWISE
Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRx™
18 Oct 2021 //
CARDIOLRX
Cardiol Receives FDA Clearance of (IND) Application of CardiolRx
24 Aug 2021 //
PRESS RELEASE
Cardiol Therapeutics Announces First Patient Enrolled in LANCER, a Phase II/III
28 Apr 2021 //
PRESS RELEASE
Cardiol says CardiolRx safe and well tolerated in Ph I study
13 Apr 2021 //
PROATIVEINVESTORS

Market Place
Sourcing Support